These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 27490009)

  • 1. Morphological and dynamic contrast enhanced MR imaging features for the differentiation of chordoma and giant cell tumors in the Axial Skeleton.
    Lang N; Su MY; Xing X; Yu HJ; Yuan H
    J Magn Reson Imaging; 2017 Apr; 45(4):1068-1075. PubMed ID: 27490009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of Spinal Lesions Using Heuristic and Pharmacokinetic Parameters Measured by Dynamic Contrast-Enhanced MRI.
    Lang N; Yuan H; Yu HJ; Su MY
    Acad Radiol; 2017 Jul; 24(7):867-875. PubMed ID: 28162875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic performance of diffusion-weighted (DWI) and dynamic contrast-enhanced (DCE) MRI for the differentiation of benign from malignant soft-tissue tumors.
    Choi YJ; Lee IS; Song YS; Kim JI; Choi KU; Song JW
    J Magn Reson Imaging; 2019 Sep; 50(3):798-809. PubMed ID: 30663160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiating between benign and malignant sinonasal lesions using dynamic contrast-enhanced MRI and intravoxel incoherent motion.
    Jiang J; Xiao Z; Tang Z; Zhong Y; Qiang J
    Eur J Radiol; 2018 Jan; 98():7-13. PubMed ID: 29279173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Triple-Classification Radiomics Model for the Differentiation of Primary Chordoma, Giant Cell Tumor, and Metastatic Tumor of Sacrum Based on T2-Weighted and Contrast-Enhanced T1-Weighted MRI.
    Yin P; Mao N; Zhao C; Wu J; Chen L; Hong N
    J Magn Reson Imaging; 2019 Mar; 49(3):752-759. PubMed ID: 30430686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of whole-lesion histogram analysis of pharmacokinetic parameters in dynamic contrast-enhanced MRI of breast lesions with the CAIPIRINHA-Dixon-TWIST-VIBE technique.
    Li Z; Ai T; Hu Y; Yan X; Nickel MD; Xu X; Xia L
    J Magn Reson Imaging; 2018 Jan; 47(1):91-96. PubMed ID: 28577335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Textural features of dynamic contrast-enhanced MRI derived model-free and model-based parameter maps in glioma grading.
    Xie T; Chen X; Fang J; Kang H; Xue W; Tong H; Cao P; Wang S; Yang Y; Zhang W
    J Magn Reson Imaging; 2018 Apr; 47(4):1099-1111. PubMed ID: 28845594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiparametric quantitative analysis of tumor perfusion and diffusion with 3T MRI: differentiation between benign and malignant soft tissue tumors.
    Lee SK; Jee WH; Jung CK; Chung YG
    Br J Radiol; 2020 Nov; 93(1115):20191035. PubMed ID: 32649224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of intravoxel incoherent motion diffusion-weighted MR imaging with dynamic contrast-enhanced MRI for differentiating lung cancer from benign solitary pulmonary lesions.
    Yuan M; Zhang YD; Zhu C; Yu TF; Shi HB; Shi ZF; Li H; Wu JF
    J Magn Reson Imaging; 2016 Mar; 43(3):669-79. PubMed ID: 26340144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DCE-MRI of the prostate using shutter-speed vs. Tofts model for tumor characterization and assessment of aggressiveness.
    Hectors SJ; Besa C; Wagner M; Jajamovich GH; Haines GK; Lewis S; Tewari A; Rastinehad A; Huang W; Taouli B
    J Magn Reson Imaging; 2017 Sep; 46(3):837-849. PubMed ID: 28092414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of focal indeterminate marrow abnormalities with multiparametric MRI.
    Baik JS; Jung JY; Jee WH; Chun CW; Kim SK; Shin SH; Chung YG; Jung CK; Kannengiesser S; Sohn Y
    J Magn Reson Imaging; 2017 Jul; 46(1):49-60. PubMed ID: 27859835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perfusion-sensitive parameters of intravoxel incoherent motion MRI in rectal cancer: evaluation of reproducibility and correlation with dynamic contrast-enhanced MRI.
    Yang X; Xiao X; Lu B; Chen Y; Wen Z; Yu S
    Acta Radiol; 2019 May; 60(5):569-577. PubMed ID: 30114928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiating skull base chordomas and invasive pituitary adenomas with conventional MRI.
    Gao A; Bai J; Cheng J; Cheng X; Li S; Zhang Z; Zhang Y
    Acta Radiol; 2018 Nov; 59(11):1358-1364. PubMed ID: 29448805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of Benign from Malignant Adnexal Masses by Dynamic Contrast-Enhanced MRI (DCE-MRI): Quantitative and Semi-quantitative analysis at 3-Tesla MRI.
    Gity M; Parviz S; Saligheh Rad H; Fathi Kazerooni A; Shirali E; Shakiba M; Baikpour M
    Asian Pac J Cancer Prev; 2019 Apr; 20(4):1073-1079. PubMed ID: 31030476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined diffusion-weighted imaging and dynamic contrast-enhanced MRI for differentiating radiologically indeterminate malignant from benign orbital masses.
    Xu XQ; Qian W; Ma G; Hu H; Su GY; Liu H; Shi HB; Wu FY
    Clin Radiol; 2017 Oct; 72(10):903.e9-903.e15. PubMed ID: 28501096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer detection on dynamic contrast-enhanced MRI: computer-aided diagnosis versus single perfusion parameter maps.
    Sung YS; Kwon HJ; Park BW; Cho G; Lee CK; Cho KS; Kim JK
    AJR Am J Roentgenol; 2011 Nov; 197(5):1122-9. PubMed ID: 22021504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of liver fibrosis using pharmacokinetic parameters of dynamic contrast-enhanced magnetic resonance imaging.
    Li Z; Sun J; Chen L; Huang N; Hu P; Hu X; Han G; Zhou Y; Bai W; Niu T; Yang X
    J Magn Reson Imaging; 2016 Jul; 44(1):98-104. PubMed ID: 26707910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soft tissue sarcoma: can dynamic contrast-enhanced (DCE) MRI be used to predict the histological grade?
    Li X; Wang Q; Dou Y; Zhang Y; Tao J; Yang L; Wang S
    Skeletal Radiol; 2020 Nov; 49(11):1829-1838. PubMed ID: 32519183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of olfactory neuroblastomas from nasal squamous cell carcinomas using MR diffusion kurtosis imaging and dynamic contrast-enhanced MRI.
    Xiao Z; Tang Z; Qiang J; Qian W; Zhong Y; Wang R; Wang J; Wu L; Tang W
    J Magn Reson Imaging; 2018 Feb; 47(2):354-361. PubMed ID: 28661554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic contrast-enhanced MRI in orbital lymphoproliferative disorders: Effects of region of interest selection methods on time efficiency, measurement reproducibility, and diagnostic ability.
    Qian W; Xu XQ; Hu H; Su GY; Wu JF; Shi HB; Wu FY
    J Magn Reson Imaging; 2018 May; 47(5):1298-1305. PubMed ID: 28922524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.